X-12920755-G-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PS1_ModeratePM1PM2PM5PP3_ModeratePP5_Moderate
The NM_138636.5(TLR8):c.1715G>T(p.Gly572Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G572D) has been classified as Pathogenic.
Frequency
Consequence
NM_138636.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TLR8 | NM_138636.5 | c.1715G>T | p.Gly572Val | missense_variant | 2/2 | ENST00000218032.7 | |
TLR8-AS1 | NR_030727.1 | n.241-12422C>A | intron_variant, non_coding_transcript_variant | ||||
TLR8 | NM_016610.4 | c.1769G>T | p.Gly590Val | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TLR8 | ENST00000218032.7 | c.1715G>T | p.Gly572Val | missense_variant | 2/2 | 1 | NM_138636.5 | P2 | |
TLR8 | ENST00000311912.5 | c.1769G>T | p.Gly590Val | missense_variant | 3/3 | 1 | A2 |
Frequencies
GnomAD3 genomes ? Cov.: 23
GnomAD4 exome Cov.: 33
GnomAD4 genome ? Cov.: 23
ClinVar
Submissions by phenotype
Immunodeficiency 98 with autoinflammation, X-linked Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 04, 2022 | - - |
Autoimmune hemolytic anemia;C4015070:Systemic autoinflammation Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Genomics Facility, Ludwig-Maximilians-Universität München | Feb 08, 2022 | The variant p.Gly572Val in TLR8 (Toll Like Receptor 8) was recently described as a loss-of-function variant for TLR8. Loss-of-function variants in TLR8 lead to X-linked recessive "severe autoimmune hemolytic anemia and autoinflammation" (Fejtkova et al. 2022; PMID: 34981838). Interestingly the variant p.Gly572Asp, at the same position but with negatively charged aspartate, is a gain-of-function variant for TLR8 in patients with X-linked recessive "immunodeficiency and bone marrow failure syndrome" (Aluri et al. 2021; PMID: 33512449). According to Fejtkova (2022), patients with “loss-of-function” in TLR8 are characterized by severe autoimmune anemia, which worsens due to infection, as well as autoinflammation in the form of fever, enteritis, arthritis and cerebral vasculitis. "Gain-of-function" variants are described according to Aluri (2021) with neutropenia, infections, lymphoproliferation, humoral immunodeficiency and, in some cases, bone marrow failure. The allele frequency database GnomAD (version v2.1.1), with mainly healthy subjects, does not yet list any heterozygous, homozygous or hemizyotic carriers of the variant p.Gly572Val. The protein encoded by TLR8, also called CD288, has 1059 amino acids and is a Toll-like receptor. This class of receptors functions as part of the innate immune response as so-called pattern-recognition receptors, i.e. they recognize structures of pathogens, such as specific RNA structures, which are not otherwise found in human cells. For example, it has been described for TLR8, an endosomal receptor, that it recognizes single-stranded RNA (ssRNA) of certain viruses and can support a corresponding immune response. The importance of the change in p.Gly572Val for the protein is predicted by the computer algorithms PolyPhen and SIFT as probably_damaging (0.999) and deleterious (0), respectively. The CADD score is 25.8 and thus an indication of a harmful change in the protein. This supports the clinical assessment by Fejtkova et al. 2022 as a loss-of-function variant. It seems plausible that the variant identified in our patient, p.Gly572Val, should have more of a destabilizing effect on the TLR8 dimer, since valine is a non-polar amino acid and therefore a loss-of -function is more likely. The variant in TLR8 is therefore the cause of our patient`s disease, and the variant is classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.